US EditionPublished • loading... • Updated
First Negotiated Medicare Drug Prices Go Into Effect Jan. 1
Medicare Part D and Advantage plans now benefit from negotiated drug prices cutting list prices by 38% to 79%, reducing costs for millions of beneficiaries.
- The Medicare Drug Price Negotiation Program required Health and Human Services to negotiate maximum prices for 10 popular drugs each year starting in 2026.
- The negotiated prices for drugs like Eliquis, Enbrel, and Januvia range from 38% to 79% below their list prices and went into effect on January 1, 2023.
- Any savings for Medicare Part D and Advantage plan enrollees depend largely on which specific plan they are enrolled in.
Insights by Ground AI
13 Articles
13 Articles
Medicare's Drug Price Bombshell, 79% Cuts Hit Big Pharma
Negotiated lower costs for 10 widely used prescription drugs under Medicare went into effect Thursday, marking the first implementation of price limits authorized by the 2022 Inflation Reduction Act. The changes cap what drug manufacturers can charge Medicare plans for select medications, but it remains unclear how much of those savings will flow directly to Medicare Part D and Medicare Advantage enrollees, given the complexity and opacity of dr…
Coverage Details
Total News Sources13
Leaning Left1Leaning Right4Center6Last UpdatedBias Distribution55% Center
Bias Distribution
- 55% of the sources are Center
55% Center
C 55%
R 36%
Factuality
To view factuality data please Upgrade to Premium
